Correction: ZHX2 drives cell growth and migration via activating MEK/ERK signal and induces Sunitinib resistance by regulating the autophagy in clear cell Renal Cell Carcinoma
- PMID: 33854032
- PMCID: PMC8046752
- DOI: 10.1038/s41419-021-03678-9
Correction: ZHX2 drives cell growth and migration via activating MEK/ERK signal and induces Sunitinib resistance by regulating the autophagy in clear cell Renal Cell Carcinoma
Figures

Erratum for
-
ZHX2 drives cell growth and migration via activating MEK/ERK signal and induces Sunitinib resistance by regulating the autophagy in clear cell Renal Cell Carcinoma.Cell Death Dis. 2020 May 7;11(5):337. doi: 10.1038/s41419-020-2541-x. Cell Death Dis. 2020. PMID: 32382017 Free PMC article.
Similar articles
-
ZHX2 drives cell growth and migration via activating MEK/ERK signal and induces Sunitinib resistance by regulating the autophagy in clear cell Renal Cell Carcinoma.Cell Death Dis. 2020 May 7;11(5):337. doi: 10.1038/s41419-020-2541-x. Cell Death Dis. 2020. PMID: 32382017 Free PMC article.
-
SOX9 was involved in TKIs resistance in renal cell carcinoma via Raf/MEK/ERK signaling pathway.Int J Clin Exp Pathol. 2015 Apr 1;8(4):3871-81. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 26097571 Free PMC article.
-
[Expression of MEK/ERK signal pathways in renal cell carcinoma with bone metastasis].Beijing Da Xue Xue Bao Yi Xue Ban. 2016 Aug 18;48(4):590-593. Beijing Da Xue Xue Bao Yi Xue Ban. 2016. PMID: 29263494 Chinese.
-
Sunitinib inhibits MEK/ERK and SAPK/JNK pathways and increases sodium/iodide symporter expression in papillary thyroid cancer.Thyroid. 2010 Sep;20(9):965-74. doi: 10.1089/thy.2010.0008. Thyroid. 2010. PMID: 20629553
-
The tumour suppressor DiRas3 interacts with C-RAF and downregulates MEK activity to restrict cell migration.Biol Cell. 2013 Feb;105(2):91-107. doi: 10.1111/boc.201200030. Epub 2012 Dec 28. Biol Cell. 2013. PMID: 23157514
Cited by
-
Autophagy inhibition potentiates anti-cancer activity of Sunitinib in kidney cancer cells.Biol Direct. 2025 Jul 15;20(1):82. doi: 10.1186/s13062-025-00671-6. Biol Direct. 2025. PMID: 40665378 Free PMC article.
-
Inhibiting stanniocalcin 2 reduces sunitinib resistance of Caki-1 renal cancer cells under hypoxia condition.Ann Med Surg (Lond). 2023 Nov 1;85(12):5963-5971. doi: 10.1097/MS9.0000000000001450. eCollection 2023 Dec. Ann Med Surg (Lond). 2023. PMID: 38098599 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous